+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shrimp Disease Diagnostics Market - Global Forecast 2026-2032- Product Image
Shrimp Disease Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Shrimp Disease Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5017278
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Shrimp Disease Diagnostics Market is projected to reach USD 539.33 Million in 2026. It is expected to continue growing at a CAGR of 8.43%, reaching USD 894.80 Million by 2032.

Shrimp disease diagnostics is becoming a strategic control point for sustainable aquaculture, seafood trade, and biosecurity. Viral, bacterial, fungal, and parasitic conditions such as white spot syndrome virus (WSSV), acute hepatopancreatic necrosis disease (AHPND), Enterocytozoon hepatopenaei (EHP), infectious hypodermal and hematopoietic necrosis virus (IHHNV), Taura syndrome virus (TSV), and infectious myonecrosis virus (IMNV) continue to shape farm productivity, survival rates, and market access.

The market is moving from symptom-based farm decisions toward evidence-led testing using PCR, qPCR, loop-mediated isothermal amplification, immunoassays, histopathology, sequencing, and digital surveillance. Demand is strongest where shrimp farming, hatchery management, broodstock screening, feed optimization, biosecurity protocols, and export certification intersect, making accurate shrimp pathogen detection essential for risk reduction, traceable production, and premium supply assurance.

Transformative Shifts in Shrimp Diagnostics

The shrimp disease diagnostics landscape is shifting from reactive outbreak confirmation to preventive health intelligence. Farms, hatcheries, processors, and veterinary laboratories are increasingly adopting routine surveillance to detect pathogens before clinical signs appear, particularly for high-impact diseases recognized by the World Organisation for Animal Health and national aquatic animal health authorities.

A second shift is the decentralization of testing. Portable PCR, LAMP-based assays, rapid sample preparation, cloud-connected reporting, and farm-level sampling protocols are shortening decision cycles. This transformation supports faster pond segregation, seed selection, water-quality intervention, movement controls, and harvest timing, while strengthening traceability for importers, retailers, and food safety regulators.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of shrimp disease diagnostics by connecting laboratory results with environmental, operational, and production data. Machine learning models can analyze patterns in water temperature, salinity, dissolved oxygen, stocking density, feed conversion, mortality, weather variability, and pathogen load to improve early-warning systems.

AI also improves diagnostic workflow efficiency through image analysis for histopathology, automated interpretation of amplification curves, anomaly detection in surveillance datasets, and risk scoring across farms and production zones. The cumulative impact is not the replacement of validated assays, but the creation of decision-support systems that help producers prioritize sampling, predict outbreaks, allocate biosecurity resources, and respond with greater precision.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific remains the center of gravity for shrimp production and shrimp disease diagnostics because China, India, Vietnam, Indonesia, Thailand, Bangladesh, and other regional producers support large aquaculture footprints and export-oriented supply chains. Regional priorities include hatchery biosecurity, post-larvae screening, WSSV control, AHPND monitoring, EHP management, broodstock certification, and farm-level surveillance, with increasing use of qPCR, PCR panels, and molecular pathogen detection to support disease prevention and movement control.

North America and Europe are comparatively smaller shrimp farming regions but influential diagnostic, regulatory, and seafood-import markets. The United States, Canada, the European Union, and the United Kingdom emphasize food safety, pathogen documentation, laboratory accreditation, traceability, and import compliance. Latin America, led by Ecuador, Mexico, and Brazil, is strengthening farm surveillance, hatchery quality programs, and export assurance as shrimp trade expands. The Middle East is advancing controlled-environment aquaculture, food security strategies, and aquatic animal health capacity, while Africa is building biosecure aquaculture zones, diagnostic access, and climate-resilient disease monitoring to support emerging shrimp farming systems.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is a critical diagnostic demand cluster because several member economies are major shrimp producers and exporters, with disease control priorities centered on hatchery certification, farm biosecurity, post-larvae quality, and rapid response to transboundary aquatic animal diseases. The region’s focus is moving toward harmonized testing practices, molecular surveillance, and stronger reporting systems to support seafood trade and improve confidence in shrimp supply chains.

The European Union and G7 influence global diagnostic standards through import controls, laboratory quality systems, research funding, food safety requirements, and seafood traceability expectations. BRICS countries represent large production, consumption, and biotechnology capacity, creating demand for scalable testing infrastructure and locally adaptable diagnostic platforms. GCC markets are investing in food security, controlled aquaculture, and aquatic health programs suited to arid environments, while NATO economies contribute advanced biotechnology, surveillance systems, risk analytics, and biosecurity research relevant to aquatic animal health and shrimp pathogen detection.

Key Country Insights Across Major Shrimp Diagnostics Markets

The United States and Canada are important for advanced diagnostics, reference laboratory capabilities, import oversight, seafood safety systems, and aquaculture health research, while Mexico and Brazil support regional diagnostic demand through shrimp farming, hatchery screening, and disease surveillance. The United Kingdom, Germany, France, Italy, and Spain influence European testing demand through seafood import requirements, veterinary diagnostics, biotechnology development, laboratory standards, and consumer expectations for traceable aquatic products.

China and India are among the most important country markets due to large shrimp aquaculture footprints, hatchery networks, recurring disease-management needs, and increasing use of molecular testing for pathogens such as WSSV, AHPND, EHP, and IHHNV. Japan and South Korea contribute high-value seafood demand, diagnostic technology adoption, and stringent quality expectations, while Australia applies strong biosecurity frameworks to protect domestic aquatic resources and manage aquatic animal disease risks. Russia remains relevant through seafood trade, cold-chain logistics, veterinary oversight, and demand for documented product safety across import and distribution channels.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated molecular diagnostics, standardized sampling, and routine screening across broodstock, hatcheries, nurseries, grow-out ponds, and processing interfaces. Integrating WSSV, AHPND, EHP, IHHNV, TSV, and IMNV panels into preventive health programs can reduce uncertainty, improve harvest planning, and support biosecurity decisions before mortality events escalate.

Organizations should also build data partnerships among farms, laboratories, feed suppliers, insurers, certification bodies, and buyers. Investments in AI-ready data architecture, technician training, quality assurance, rapid reporting, and interoperable laboratory information systems will convert diagnostic results into operational decisions and strengthen confidence across export-oriented seafood supply chains.

Research Methodology

The research methodology should combine secondary and primary intelligence from authoritative sources, including FAO aquaculture data, World Organisation for Animal Health aquatic animal health guidance, national veterinary authorities, peer-reviewed journals, diagnostic assay documentation, trade statistics, regulatory publications, and expert interviews with aquatic health specialists, laboratory professionals, producers, and supply-chain stakeholders.

Market assessment should triangulate disease prevalence indicators, aquaculture production patterns, diagnostic technology adoption, regulatory requirements, laboratory capacity, and buyer traceability expectations. A robust methodology also evaluates assay performance characteristics such as sensitivity, specificity, validation status, repeatability, throughput, turnaround time, cost per test, biosafety requirements, sample matrix compatibility, and field usability.

Conclusion

Shrimp disease diagnostics is transitioning from a laboratory service into a core aquaculture management capability. As disease pressure, climate variability, export scrutiny, antimicrobial stewardship, and production intensification increase, reliable pathogen detection will remain central to farm profitability, aquatic biosecurity, and seafood supply resilience.

The strongest opportunities will emerge where validated testing, AI-enabled risk analytics, regional biosecurity, and interoperable reporting converge. Organizations that treat diagnostics as a continuous intelligence system rather than an occasional outbreak tool will be best positioned to protect shrimp health, maintain market access, and support long-term aquaculture sustainability.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Shrimp Disease Diagnostics Market, by Technology
7.1. Introduction
7.2. Enzyme Linked Immunosorbent Assay
7.3. Loop Mediated Isothermal Amplification
7.4. Next Generation Sequencing
7.5. Polymerase Chain Reaction
7.5.1. Multiplex PCR
7.5.2. Quantitative PCR
7.5.3. Reverse Transcription PCR
8. Shrimp Disease Diagnostics Market, by Diagnostic Method
8.1. Introduction
8.2. Histopathological Diagnostics
8.3. Immunological Diagnostics
8.3.1. Enzyme Linked Immunosorbent Assay
8.3.2. Lateral Flow Immunoassay
8.3.3. Western Blot
8.4. Microbiological Diagnostics
8.5. Molecular Diagnostics
9. Shrimp Disease Diagnostics Market, by Disease Type
9.1. Introduction
9.2. Bacterial Diseases
9.3. Fungal Diseases
9.4. Parasitic Diseases
9.5. Viral Diseases
10. Shrimp Disease Diagnostics Market, by Application
10.1. Introduction
10.2. Monitoring
10.3. Outbreak Investigation
10.4. Research
10.5. Screening
11. Shrimp Disease Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Aquaculture Farms
11.4. Diagnostic Laboratories
11.5. Research Institutes
12. Shrimp Disease Diagnostics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Shrimp Disease Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Shrimp Disease Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 3 Little Fish Sdn Bhd
16.2. Amazing Biotech
16.3. Aquaintech Inc.
16.4. Arachem (M) Sdn Bhd
16.5. Bioneer Corporation
16.6. Blue Aqua International Pte. Ltd.
16.7. CD Genomics
16.8. China Guangzhou BioKey Healthy Technology Co. Ltd
16.9. DSM Austria GmbH
16.10. Forte Biotech
16.11. GeneReach Biotechnology Corporation
16.12. Genics Pty. Ltd.
16.13. Illumina, Inc.
16.14. Innocreate Bioscience Co., Ltd.
16.15. Lab-Ind Resource Sdn. Bhd.
16.16. Laboratory Corporation of America Holdings
16.17. Mahesh Aqua Holdings (Pvt) Ltd.
16.18. Mylab Discovery Solutions Pvt. Ltd.
16.19. PT Riset Nusantara Genetika (Nusantics)
16.20. Randox Laboratories Ltd.
16.21. Reagen LLC
16.22. Ring Biotechnology Co Ltd.
16.23. Speedy Assay Sdn. Bhd.
16.24. SUREBIO
16.25. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LOOP MEDIATED ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MULTIPLEX PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MULTIPLEX PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MULTIPLEX PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL QUANTITATIVE PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL QUANTITATIVE PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL QUANTITATIVE PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REVERSE TRANSCRIPTION PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REVERSE TRANSCRIPTION PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REVERSE TRANSCRIPTION PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HISTOPATHOLOGICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HISTOPATHOLOGICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HISTOPATHOLOGICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOLOGICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOLOGICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOLOGICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ENZYME LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL WESTERN BLOT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL WESTERN BLOT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MICROBIOLOGICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MICROBIOLOGICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MICROBIOLOGICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FUNGAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL FUNGAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL FUNGAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL VIRAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL VIRAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL VIRAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL OUTBREAK INVESTIGATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL OUTBREAK INVESTIGATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL OUTBREAK INVESTIGATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL AQUACULTURE FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 113. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 114. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 115. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 116. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 117. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 127. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 130. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 131. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 132. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 133. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 138. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 139. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 140. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 141. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 142. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 143. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 147. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 148. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 149. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 150. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 162. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 163. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 164. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 165. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 166. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 169. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 170. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 171. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 172. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 173. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 174. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 178. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 179. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 180. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 181. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 182. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 191. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 194. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 195. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 196. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 197. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 198. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 199. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 202. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 203. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 204. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 205. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 206. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 207. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 211. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 213. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 214. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 228. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 229. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 230. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 231. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 233. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 235. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 236. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 237. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 238. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 239. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 242. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 243. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 244. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 245. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 246. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 247. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 251. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 252. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 253. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 254. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 255. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 260. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 261. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 262. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 263. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 268. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 269. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 270. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 271. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 276. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 277. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 278. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 279. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 284. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 285. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 286. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 287. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 291. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 292. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 293. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 294. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 295. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2017-2032 (USD MILLION)
TABLE 300. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2017-2032 (USD MILLION)
TABLE 301. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 302. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 303. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 306. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem (M) Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings (Pvt) Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika (Nusantics)
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 539.33 Million
Forecasted Market Value ( USD ) by 2032 $ 894.8 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Veterinary Reference Laboratory Market - Global Forecast 2026-2032 - Product Image

Veterinary Reference Laboratory Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Veterinary Anti-infectives Market - Global Forecast 2026-2032 - Product Image

Veterinary Anti-infectives Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Fish Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Fish Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Aquatic Veterinary Market Report 2026 - Product Image

Aquatic Veterinary Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Veterinary Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From

About the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of diseases that affect shrimp, a type of crustacean. Diagnostic tests are used to identify the presence of disease-causing agents, such as bacteria, viruses, and parasites. These tests can be used to detect the presence of disease in shrimp, as well as to monitor the effectiveness of treatments. Diagnostic tests are also used to monitor the health of shrimp populations, as well as to detect the presence of disease-causing agents in the environment. The Shrimp Disease Diagnostics market is driven by the increasing demand for shrimp, as well as the need to ensure the health and safety of shrimp populations. The market is also driven by advances in technology, such as the development of new diagnostic tests and the use of molecular techniques. Companies in the Shrimp Disease Diagnostics market include Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, and Genetwister Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.